What does Jiangsu Lianhuan Pharmaceutical Co., Ltd. do?

Jiangsu Lianhuan Pharmaceutical Co., Ltd. (600513.SS) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 600513.SS's market cap?

Jiangsu Lianhuan Pharmaceutical Co., Ltd. (600513.SS) has a market capitalization of approximately $4.58 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.

Does 600513.SS pay a dividend?

Yes — Jiangsu Lianhuan Pharmaceutical Co., Ltd. (600513.SS) pays a dividend annually, with a trailing-twelve-month yield of 0.44%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.

Is 600513.SS profitable?

Jiangsu Lianhuan Pharmaceutical Co., Ltd. (600513.SS) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

600513.SS

Jiangsu Lianhuan Pharmaceutical Co., Ltd.

SHH·Drug Manufacturers, Specialty & Generic · Healthcare

¥16.05¥0.22−1.35%

Market cap¥4.58B·Aug 26 7:00 AM UTC

Price Chart

¥16.05−¥0.22 (−1.35%)today

+91.07%CAGR +13.83%

Select date range

FromTo

Mar 19, 2003Aug 26, 2021 → Aug 26, 2026· 5.0 yrsAug 26, 2026

Key Metrics

DividendDividend Tab

Dividend Yield (FWD)0.44%

Annual Dividend (FWD)¥0.07

Dividend Growth (5Y)−8.3%

Dividend Safety—

Payout Ratio—

FCF Payout Ratio—

Most Recent Dividend¥0.070

Ex-Dividend DateJul 8

Payment DateJul 8

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateMar 28

Last Report DateJun 30

Reported vs Estimate−¥0.22

Earnings Surprise—

FinancialsFinancials Tab

Revenue¥2.89B

Net Income−¥114.97M

Net Margin−4.0%

Operating Cash Flow−¥40.32M

Capital Expenditures¥249.89M

Free Cash Flow−¥290.21M

Return on Equity−9.0%

Return on Invested Capital0.2%

Net Debt¥1.09B

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 600513.SS and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 600513.SS's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 600513.SS and 80,000+ other tickers.

About Jiangsu Lianhuan Pharmaceutical Co., Ltd.

Jiangsu Lianhuan Pharmaceutical Co., Ltd. operates within China, specializing in the production and distribution of chemical raw materials, pharmaceutical formulations, and organic intermediate compounds. Its extensive product range addresses diverse therapeutic needs, including cardiovascular issues, allergies, urinary tract conditions, infectious diseases, and immune system modulation. The enterprise was founded in 2000 and has its principal headquarters located in Yangzhou, China.

CEO: Ben Niu
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Exchange: SHH
Employees: 2,131
Website: www.lhpharma.com

Peers

Peers Tab

000078.SZ

Shenzhen Neptunus Bioengineering Co., Ltd.

Cap

¥4.3B

688566.SS

Jiangsu Jibeier Pharmaceutical Co., Ltd.

Cap

¥5.1B

002370.SZ

Zhejiang Yatai Pharmaceutical Co., Ltd.

Cap

¥4.1B

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 600513.SS

What does Jiangsu Lianhuan Pharmaceutical Co., Ltd. do?: Jiangsu Lianhuan Pharmaceutical Co., Ltd. (600513.SS) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 600513.SS's market cap?: Jiangsu Lianhuan Pharmaceutical Co., Ltd. (600513.SS) has a market capitalization of approximately $4.58 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.
Does 600513.SS pay a dividend?: Yes — Jiangsu Lianhuan Pharmaceutical Co., Ltd. (600513.SS) pays a dividend annually, with a trailing-twelve-month yield of 0.44%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.
Is 600513.SS profitable?: Jiangsu Lianhuan Pharmaceutical Co., Ltd. (600513.SS) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.